From Bench to Bedside: Insect Research Yields Promising New Drug for Diabetes, Hypertension and Inflammatory Disorders

(PhysOrg.com) -- A new drug developed at the University of California, Davis, to treat diabetes, hypertension and inflammatory diseases has entered Phase IIa of human clinical trials to evaluate its efficacy.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news155494845.html">From Bench to Bedside: Insect Research Yields Promising New Drug for Diabetes, Hypertension and Inflammatory Disorders</a></p> <p>(PhysOrg.com) -- A new drug developed at the University of California, Davis, to treat diabetes, hypertension and inflammatory diseases has entered Phase IIa of human clinical trials to evaluate its efficacy.</p>